Analysis of the cerebral transcriptome in mice subjected to traumatic brain injury: Importance of IL-6

NeuroImmunoModulation

Volumn 14, Issue 3-4, 2007, Pages 139-143

  Quintana, Albert ^a   Giralt, Mercedes ^a   Molinero, Amalia ^a   Campbell, Iain L ^b   Penkowa, Milena ^c   Hidalgo, Juan ^a  

^a INSTITUT DE NEUROCIÈNCIES   (Spain)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cryoinjury; GFAP IL6 mice; IL 6; Microarrays; Transcriptome

Indexed keywords

CYTOKINE; GROWTH FACTOR; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TISSUE INJURY; TISSUE REGENERATION; TRANSGENIC MOUSE; TRAUMATIC BRAIN INJURY;

ANIMALS; ASTROCYTES; BRAIN INJURIES; CEREBRAL CORTEX; ENCEPHALITIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; RNA, MESSENGER;

EID: 37049003280     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110637     Document Type: Conference Paper

References (44)

1. Prins ML, Hovda DA: Developing experimental models to address traumatic brain injury in children. J Neurotrauma 2003;20:123-137.
2. Aloisi F: Immune function of microglia. Glia 2001;36:165-179.
3. Allan SM, Rothwell NJ: Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001;2:734-744.
4. Lucas SM, Rothwell NJ, Gibson RM: The role of inflammation in CNS injury and disease. Br J Pharmacol 2006;147(suppl 1):S232-S240.
5. Halliwell B: Reactive oxygen species and the central nervous system. J Neurochem 1992;59:1609-1623.
6. Coyle J, Puttfarcken P: Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993;262:689-695.
7. Block ML, Zecca L, Hong JS: Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007;8:57-69.
8. Penkowa M, Carrasco J, Giralt M, Moos T, Hidalgo J: CNS wound healing is severely depressed in metallothionein I- and II-deficient mice. J Neurosci 1999;19:2535-2545.
9. Penkowa M, Carrasco J, Giralt M, Molinero A, Hernández J, Campbell IL, Hidalgo J: Altered central nervous system cytokinegrowth factor expression profiles and angiogenesis in metallothionein-I+II deficient mice. J Cereb Blood Flow Metab 2000;20:1174-1189.
10. Penkowa M, Giralt M, Thomsen P, Carrasco J, Hidalgo J: Zinc or copper deficiency-induced impaired inflammatory response to brain trauma may be caused by the concomitant metallothionein changes. J Neurotrauma 2001;18:447-463.
11. Giralt M, Penkowa M, Lago N, Molinero A, Hidalgo J: Metallothionein-1+2 protect the CNS after a focal brain injury. Exp Neurol 2002;173:114-128.
12. Penkowa M, Hidalgo J: Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis. Glia 2000;32:247-263.
13. Carrasco J, Penkowa M, Hadberg H, Molinero A, Hidalgo J: Enhanced seizures and hippocampal neurodegeneration following kainic acid induced seizures in metallothionein-I+II deficient mice. Eur J Neurosci 2000;12:2311-2322.
14. Lee DK, Carrasco J, Hidalgo J, Andrews GK: Identification of a signal transducer and activator of transcription (STAT) binding site in the mouse metallothionein- I promoter involved in interleukin-6-induced gene expression. Biochem J 1999;337:59-65.
15. Giralt M, Penkowa M, Hernández J, Molinero A, Carrasco J, Lago N, Camats J, Campbell IL, Hidalgo J: Metallothionein-1+2 deficiency increases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin 6. Neurobiol Dis 2002;9:319-338.
16. Molinero A, Penkowa M, Hernández J, Camats J, Giralt M, Lago N, Carrasco J, Campbell IL, Hidalgo J: Metallothionein-I overexpression decreases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin 6. J Neuropathol Exp Neurol 2003;62:315-328.
17. Campbell IL: Transgenic mice and cytokine actions in the brain: bridging the gap between structural and functional neuropathology. Brain Res Rev 1998;26:327-336.
18. Bauer S, Kerr BJ, Patterson PH: The neuropoietic cytokine family in development, plasticity, disease and injury. Nat Rev Neurosci 2007;8:221-232.
19. Insel TR, Volkow ND, Landis SC, Li TK, Battey JF, Sieving P: Limits to growth: why neuroscience needs large-scale science. Nat Neurosci 2004;7:426-427.
20. Mirnics K, Pevsner J: Progress in the use of microarray technology to study the neurobiology of disease. Nat Neurosci 2004;7:434-439.
21. Read SJ, Parsons AA, Harrison DC, Philpott K, Kabnick K, O'Brien S, Clark S, Brawner M, Bates S, Gloger I, Legos JJ, Barone FC: Stroke genomics: approaches to identify, validate, and understand ischemic stroke gene expression. J Cereb Blood Flow Metab 2001;21:755-778.
22. Tang Y, Lu A, Aronow BJ, Wagner KR, Sharp FR: Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur J Neurosci 2002;15:1937-1952.
23. Natale JE, Ahmed F, Cernak I, Stoica B, Faden AI: Gene expression profile changes are commonly modulated across models and species after traumatic brain injury. J Neurotrauma 2003;20:907-927.
24. Kury P, Schroeter M, Jander S: Transcriptional response to circumscribed cortical brain ischemia: spatiotemporal patterns in ischemic vs. remote non-ischemic cortex. Eur J Neurosci 2004;19:1708-1720.
25. Dhodda VK, Sailor KA, Bowen KK, Vemuganti R: Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J Neurochem 2004;89:73-89.
26. Roth A, Gill R, Certa U: Temporal and spatial gene expression patterns after experimental stroke in a rat model and characterization of PC4, a potential regulator of transcription. Mol Cell Neurosci 2003;22:353-364.
27. Long Y, Zou L, Liu H, Lu H, Yuan X, Robertson CS, Yang K: Altered expression of randomly selected genes in mouse hippocampus after traumatic brain injury. J Neurosci Res 2003;71:710-720.
28. Faden AI, Movsesyan VA, Knoblach SM, Ahmed F, Cernak I: Neuroprotective effects of novel small peptides in vitro and after brain injury. Neuropharmacology 2005;49:410-424.
29. Lu XC, Williams AJ, Yao C, Berti R, Hartings JA, Whipple R, Vahey MT, Polavarapu RG, Woller KL, Tortella FC, Dave JR: Microarray analysis of acute and delayed gene expression profile in rats after focal ischemic brain injury and reperfusion. J Neurosci Res 2004;77:843-857.
30. Natale JE, Knight JB, Cheng Y, Rome JE, Gallo V: Metallothionein I and II mitigate age-dependent secondary brain injury. J Neurosci Res 2004;78:303-314.
31. Rao VLR, Dhodda VK, Song G, Bowen KK, Dempsey RJ: Traumatic brain injury-induced acute gene expression changes in rat cerebral cortex identified by genechip analysis. J Neurosci Res 2003;71:208-219.
32. Dash PK, Kobori N, Moore AN: A molecular description of brain trauma pathophysiology using microarray technology: an overview. Neurochem Res 2004;29:1275-1286.
33. Gebicke-Haerter PJ: Microarrays and expression profiling in microglia research and in inflammatory brain disorders. J Neurosci Res 2005;81:327-341.
34. Collins FS, Rossant J, Wurst W: A mouse for all reasons. Cell 2007;128:9-13.
35. Poulsen CB, Penkowa M, Borup R, Nielsen FC, Caceres M, Quintana A, Molinero A, Carrasco J, Giralt M, Hidalgo J: Brain response to traumatic brain injury in wildtype and interleukin-6 knockout mice: a microarray analysis. J Neurochem 2005;92:417-432.
36. Quintana A, Molinero A, Florit S, Manso Y, Comes G, Carrasco J, Giralt M, Borup R, Nielsen FC, Campbell IL, Penkowa M, Hidalgo J: Diverging mechanisms for TNF-α receptors in normal mouse brains and in functional recovery after injury: from gene to behavior. J Neurosci Res 2007;85:2668-2685.
37. Penkowa M, Cáceres M, Borup R, Nielsen FC, Poulsen CB, Quintana A, Molinero A, Carrasco J, Florit S, Giralt M, Hidalgo J: Novel roles for metallothionein-I+II (MT-I+II) in defense responses, neurogenesis and tissue restoration after traumatic brain injury: insights from global gene expression profiling in wild-type and MT-I+II knockout mice. J Neurosci Res 2006;84:1452-1474.
38. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MBA, Mucke L: Neurologic disease in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 1993;90:10061-10065.
39. Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH: Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci USA 1997;94:1500-1505.
40. Swartz KR, Liu F, Sewell D, Schochet T, Campbell I, Sandor M, Fabry Z: Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res 2001;896: 86-95.
41. Penkowa M, Giralt M, Lago N, Camats J, Carrasco J, Hernández J, Molinero A, Campbell IL, Hidalgo J: Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp Neurol 2003;181:130-148.
42. Li C, Wong WH: Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001;98:31-36.
43. Penkowa M, Giralt M, Carrasco J, Hadberg H, Hidalgo J: Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice. Glia 2000;32:271-285.
44. Liu PK, Grossman RG, Hsu CY, Robertson CS: Ischemic injury and faulty gene transcripts in the brain. Trends Neurosci 2001;24:581-588.